Indefinite Delivery Contract HHSN268201600036I

Ended Awarded Last action

Contract number
HHSN268201600036I
Awardee
Awarding agency
Task orders
1 $5,906,039 obligated

Award facts

Opportunity
  • NHLBICSBHV201636JES Solicitation number
Combined order value
$5,906,039 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 1% used
$505,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
10 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Heart, Lung, and Blood Institute awarded a multiple-award Indefinite Delivery/Indefinite Quantity contract valued at $505 million to New York Genome Center, Inc. for the Centralized Omics Resource (CORE) program, a component of the Trans-Omics for Precision Medicine (TOPMed) initiative. The contract, effective from September 26, 2016, through September 25, 2023, procures centralized omics data analysis and management services to support precision medicine research. As a non-profit academic research institution specializing in advanced genomic sequencing and computational analysis, NYGC provides next-generation sequencing, whole genome sequencing, RNA sequencing, and comprehensive genomic characterization services. The contract was awarded without set-asides, reflecting the specialized technical expertise required to execute complex genomic research requirements for federal biomedical research initiatives.

Task order execution under this IDV vehicle demonstrates ongoing operational deployment of NYGC's genomic services. A representative delivery order issued in September 2020 for the fifth year of the CORE project, valued at $5,906,039 and scheduled for completion by September 27, 2024, illustrates the firm fixed-price structure applied to annual program increments. The work is performed at the Bethesda, Maryland location, supporting the TOPMed program's objective to advance precision medicine through comprehensive omics data generation and analysis. NYGC's established capacity in handling large-scale sequencing operations, combined with its collaborative relationships across major academic and research institutions, positions the organization to deliver the centralized analytical infrastructure necessary for the multi-year, multi-disciplinary precision medicine research supported through this contract vehicle.

Task orders

Task order Ordering agency Obligated Awarded
Centralized omics resource (core) year 5 75N92020F00001 National Heart Lung and Blood Institute (NIH) $5,906,039

Transactions

Action Obligated Date
Other Administrative Action P00003 · Centralized omics resource (core) $0
Supplemental Agreement for work within scope P00002 · The purpose of this modification is to include far deviation clause 52.223-99 - ensuring adequate covid safety protocols for federal contractors pursuant with… $0
Other Administrative Action P00001 $0
Original award Centralized omics resource (core) $0

Quick answers

Who was awarded contract HHSN268201600036I?

HHSN268201600036I was awarded to New York Genome Center, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 26, 2016.

How much is contract HHSN268201600036I worth?

Orders under HHSN268201600036I have obligated $5,906,039. HHSN268201600036I's own ceiling is $505,000,000.

How many orders have been placed under contract HHSN268201600036I?

1 order has been placed under HHSN268201600036I, the latest on September 28, 2020.

Who can order from contract HHSN268201600036I?

HHSN268201600036I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN268201600036I part of a contract vehicle?

Yes. HHSN268201600036I is part of Centralized Omic REsource for TOPMed (CORE).

Was contract HHSN268201600036I competed?

The government received 10 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV